Exemestane 25 mg administered as soon as day by day was evaluated in a very randomized double-blind, multicenter, multinational comparative review and in two multicenter one-arm scientific tests of postmenopausal Women of all ages with Highly developed breast cancer who experienced disease development soon after therapy with tamoxifen for metastati